Deep Track Capital, LP
64 holdingsFiling period: 2026-03-31Current AUM: $7.42Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | XBI | SPDR SERIES TRUST | 10.00M | $1.28B | $1.47B | 19.82% | -- | 2026-03-31 |
| 2 | GH | GUARDANT HEALTH INC | 3.34M | $308.4M | $540.8M | 7.29% | +538.2K | 2026-03-31 |
| 3 | IMVT | IMMUNOVANT INC | 11.53M | $286.3M | $445.2M | 6.00% | -- | 2026-03-31 |
| 4 | TARS | TARSUS PHARMACEUTICALS INC | 3.60M | $252.5M | $212.5M | 2.87% | +596.0K | 2026-03-31 |
| 5 | PCVX | VAXCYTE INC | 4.30M | $249.9M | $232.5M | 3.14% | +300.0K | 2026-03-31 |
| 6 | GPCR | STRUCTURE THERAPEUTICS INC | 4.28M | $206.3M | $205.6M | 2.77% | +168.1K | 2026-03-31 |
| 7 | AXSM | AXSOME THERAPEUTICS INC. | 1.10M | $185.9M | $239.8M | 3.23% | -50,000 | 2026-03-31 |
| 8 | APLS | APELLIS PHARMACEUTICALS INC | 4.53M | $182.3M | $182.3M | 2.46% | -3,217,626 | 2026-03-31 |
| 9 | OCUL | OCULAR THERAPEUTIX INC | 19.69M | $166.7M | $160.8M | 2.17% | +11.62M | 2026-03-31 |
| 10 | VERA | VERA THERAPEUTICS INC | 4.11M | $165.2M | $131.8M | 1.78% | +1.28M | 2026-03-31 |
| 11 | ALMS | ALUMIS INC | 6.77M | $149.2M | $191.3M | 2.58% | -- | 2026-03-31 |
| 12 | IONS | IONIS PHARMACEUTICALS INC | 1.95M | $146.4M | $101.0M | 1.36% | +250.0K | 2026-03-31 |
| 13 | NUVL | NUVALENT INC | 1.38M | $141.0M | $141.0M | 1.90% | -- | 2026-03-31 |
| 14 | — | ALKERMES PLC | 3.59M | $127.0M | $127.0M | 1.71% | +1.59M | 2026-03-31 |
| 15 | CNTA | CENTESSA PHARMACEUTICALS PLC | 3.16M | $125.4M | $125.4M | 1.69% | +1.16M | 2026-03-31 |
| 16 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 6.41M | $119.5M | $118.2M | 1.59% | +1.80M | 2026-03-31 |
| 17 | MAZE | MAZE THERAPEUTICS INC | 3.48M | $103.8M | $93.6M | 1.26% | -768,878 | 2026-03-31 |
| 18 | ORKA | ORUKA THERAPEUTICS INC | 2.03M | $99.8M | $196.3M | 2.65% | -127,307 | 2026-03-31 |
| 19 | NRIX | NURIX THERAPEUTICS INC | 6.35M | $98.4M | $147.3M | 1.99% | -691,211 | 2026-03-31 |
| 20 | GMAB | GENMAB A/S | 3.66M | $98.3M | $105.8M | 1.43% | -- | 2026-03-31 |
| 21 | CYTK | CYTOKINETICS INC | 1.37M | $90.6M | $106.0M | 1.43% | -1,962,678 | 2026-03-31 |
| 22 | GRAL | GRAIL INC | 1.72M | $89.0M | $118.1M | 1.59% | +700.0K | 2026-03-31 |
| 23 | LBRX | LB PHARMACEUTICALS INC | 3.35M | $82.7M | $134.4M | 1.81% | -- | 2026-03-31 |
| 24 | MBX | MBX BIOSCIENCES INC | 2.76M | $82.3M | $181.8M | 2.45% | -492,221 | 2026-03-31 |
| 25 | BCAX | BICARA THERAPEUTICS INC | 4.06M | $80.8M | $110.1M | 1.48% | +1.45M | 2026-03-31 |
← Scroll →
Page 1 of 3